Idiopathic Membranous Nephropathy Treatment Market is projected to witness substantial growth over the next few years, driven ...

A Richmond resident is among those featured in an upcoming short TV series about transplant patients. Suki Mangat, who is on ...

A novel drug significantly reduced IgA nephropathy-related proteinuria, according to interim findings of the ALIGN study. In ...

There was a clinically meaningful reduction in proteinuria with iptacopan (Fabhalta), and a confirmed clinical benefit of ...

How to Keep Your Kidneys Healthy Despite Diabetes? Here Are The Top 5 Proven Strategies To Beat The Side Effects of High Blood Sugar Levels.

The survey highlights a preference for collaborative learning methods, with 75% of respondents favoring clinical case ...

Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...

USA: An interim analysis of the Phase 3 VISIONARY study revealed that sibeprenlimab achieved a significant and clinically ...

The global IgA nephropathy market is set to experience significant growth over the next decade, with the market expected to be valued at USD 41.24 billion in 2023. According to a new report, the ...

IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase II trial revealed that felzartamab, an ...

IgA nephropathy is the most common primary glomerulonephritis and contributes to kidney failure. Growing evidence exists that the overactivation of the lectin pathway contributes to the pathogenesis ...

The healthcare provider offers an integrated approach to diabetes care across its facilities, including BMC, Burjeel, Medeor, ...